Vertex Pharmaceuticals
Philip Harder Delff, PhD, is an accomplished professional in the field of modeling and simulations with significant experience in the pharmaceutical industry. Currently serving as Director of Modeling & Simulations at Vertex Pharmaceuticals, Philip previously held positions as Associate Director at AstraZeneca and as Senior Modelling Scientist and Modelling Scientist at Novo Nordisk. Earlier in the career, Philip worked as a Statistician at Danmarks Statistik and contributed as a Research Assistant and Lecturer at the Technical University of Denmark while also completing a PhD. Philip's extensive background combines advanced statistical expertise with strong leadership roles in pharmaceutical research and development.
This person is not in any teams
Vertex Pharmaceuticals
87 followers
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.